A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is
O25 Alcohol related liver disease: delayed diagnosis and missed opportunities for intervention
hypertension. The difference in all-cause and liver-related mortality suggests that this survival benefit may not be entirely liver related. REFERENCES 1. Sinha R, Lockman KA, Mallawaarachchi N, Robertson M, Plevris JN, Hayes PC. Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites. Abstract O23 Figure 1 Abstract O24 Figure 1 Change from baseline in ALP and total bilirubin through 72 months of OCA treatment Abstracts Gut 2021;70(Suppl 1):A1-A262 A13doi:10.1136/gutjnl-2020-bsgcampus.25 fatcat:bnjvskivvnahpkmejalq4qafdm